Marvell Technology, PayPal, Rubrik And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

Clinuvel Pharmaceuticals shares are trading lower after the company reported weak FY26 financial results.

HP, Best Buy Dollar Tree And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

U.S. stock futures mixed, HP Inc shares fall in pre-market trading after beating earnings estimates and raising guidance. Other stocks also down.

A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

CLINUVEL Pharmaceuticals announced its tenth consecutive annual profit for FY2026 with revenues of $94.0 million and net profit after tax of $33.9 million. The company declared a $0.05 per share dividend and increased cash reserves to $252.1 million, providing financial independence to pursue expansion strategy, particularly in North America. Despite marginal revenue decline due to U.S. market competition and inventory practice changes, the company maintained disciplined expense control and achieved record SCENESSE treatment volumes.

Benzinga Bulls and Bears: Nvidia, CrowdStrike, Intuit

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

'Blue Owl Leads $2.4 Billion Iren Debt Deal to Buy Nvidia’s Chips' - Bloomberg

https://www.bloomberg.com/news/articles/2026-08-28/blue-owl-leads-2-4-billion-iren-debt-deal-to-buy-nvidia-s-chips

IREN’s New AI Contract Adds to $2.8 Billion in Deals as Company Targets $4 Billion ARR, Analysts Say

BTIG reiterates its Buy rating and $80 price forecast on IREN Limited (NASDAQ: IREN) stock, pointing to new multi-year AI cloud deals and rising 2027 capacity contracting.